Global Varicella Vaccine Market Insights, Forecast to 2026
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
As for the global varicella vaccine industry, the industry structure is relatively concentrated. The 72.50% of market share in production is grasped by the top 5 manufacturers. The top three manufacturers are Merck, GSK and Shanghai Institute, which are close to 52 percent totally. The United States giant Merck, which has 30.40% market share in 2015, is the leader in the varicella vaccine industry. The manufacturers following Merck are GSK and Shanghai Institute, which respectively has 10.04% and 11.60% market share globally. The Shanghai Institute is the leader of China varicella vaccine industry.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Varicella Vaccine 3900 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Varicella Vaccine 3900 industry.
Based on our recent survey, we have several different scenarios about the Varicella Vaccine 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 3571.6 million in 2019. The market size of Varicella Vaccine 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Varicella Vaccine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Varicella Vaccine market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Varicella Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Varicella Vaccine market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Varicella Vaccine market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Varicella Vaccine market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Varicella Vaccine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Varicella Vaccine market.
The following manufacturers are covered in this report:
As for the global varicella vaccine industry, the industry structure is relatively concentrated. The 72.50% of market share in production is grasped by the top 5 manufacturers. The top three manufacturers are Merck, GSK and Shanghai Institute, which are close to 52 percent totally. The United States giant Merck, which has 30.40% market share in 2015, is the leader in the varicella vaccine industry. The manufacturers following Merck are GSK and Shanghai Institute, which respectively has 10.04% and 11.60% market share globally. The Shanghai Institute is the leader of China varicella vaccine industry.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Varicella Vaccine 3900 market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Varicella Vaccine 3900 industry.
Based on our recent survey, we have several different scenarios about the Varicella Vaccine 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 3571.6 million in 2019. The market size of Varicella Vaccine 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Varicella Vaccine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Varicella Vaccine market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Varicella Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Varicella Vaccine market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Varicella Vaccine market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Varicella Vaccine market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Varicella Vaccine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Varicella Vaccine market.
The following manufacturers are covered in this report:
- Merck
- GSK
- Shanghai Institute
- BCHT
- Changsheng
- Keygen
- Green Cross
- Biken
- Injection
- Freeze-dried powder
- Kids Injection
- Adults Injection
1 STUDY COVERAGE
1.1 Varicella Vaccine Product Introduction
1.2 Market Segments
1.3 Key Varicella Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Varicella Vaccine Market Size Growth Rate by Type
1.4.2 Injection
1.4.3 Freeze-dried powder
1.5 Market by Application
1.5.1 Global Varicella Vaccine Market Size Growth Rate by Application
1.5.2 Kids Injection
1.5.3 Adults Injection
1.6 Coronavirus Disease 2019 (Covid-19): Varicella Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the Varicella Vaccine Industry
1.6.1.1 Varicella Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Varicella Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Varicella Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Varicella Vaccine Market Size Estimates and Forecasts
2.1.1 Global Varicella Vaccine Revenue 2015-2026
2.1.2 Global Varicella Vaccine Sales 2015-2026
2.2 Varicella Vaccine Market Size by Region: 2020 Versus 2026
2.2.1 Global Varicella Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Varicella Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL VARICELLA VACCINE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Varicella Vaccine Sales by Manufacturers
3.1.1 Varicella Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Varicella Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Varicella Vaccine Revenue by Manufacturers
3.2.1 Varicella Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Varicella Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Varicella Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Varicella Vaccine Revenue in 2019
3.2.5 Global Varicella Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Varicella Vaccine Price by Manufacturers
3.4 Varicella Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Varicella Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Varicella Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Varicella Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Varicella Vaccine Market Size by Type (2015-2020)
4.1.1 Global Varicella Vaccine Sales by Type (2015-2020)
4.1.2 Global Varicella Vaccine Revenue by Type (2015-2020)
4.1.3 Varicella Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Varicella Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Varicella Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Varicella Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Varicella Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Varicella Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Varicella Vaccine Market Size by Application (2015-2020)
5.1.1 Global Varicella Vaccine Sales by Application (2015-2020)
5.1.2 Global Varicella Vaccine Revenue by Application (2015-2020)
5.1.3 Varicella Vaccine Price by Application (2015-2020)
5.2 Varicella Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Varicella Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Varicella Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Varicella Vaccine Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Varicella Vaccine by Country
6.1.1 North America Varicella Vaccine Sales by Country
6.1.2 North America Varicella Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Varicella Vaccine Market Facts & Figures by Type
6.3 North America Varicella Vaccine Market Facts & Figures by Application
7 EUROPE
7.1 Europe Varicella Vaccine by Country
7.1.1 Europe Varicella Vaccine Sales by Country
7.1.2 Europe Varicella Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Varicella Vaccine Market Facts & Figures by Type
7.3 Europe Varicella Vaccine Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Varicella Vaccine by Region
8.1.1 Asia Pacific Varicella Vaccine Sales by Region
8.1.2 Asia Pacific Varicella Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Varicella Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Varicella Vaccine Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Varicella Vaccine by Country
9.1.1 Latin America Varicella Vaccine Sales by Country
9.1.2 Latin America Varicella Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Varicella Vaccine Market Facts & Figures by Type
9.3 Central & South America Varicella Vaccine Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Varicella Vaccine by Country
10.1.1 Middle East and Africa Varicella Vaccine Sales by Country
10.1.2 Middle East and Africa Varicella Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Varicella Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Varicella Vaccine Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description, Business Overview and Total Revenue
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Varicella Vaccine Products Offered
11.1.5 Merck Recent Development
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Description, Business Overview and Total Revenue
11.2.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GSK Varicella Vaccine Products Offered
11.2.5 GSK Recent Development
11.3 Shanghai Institute
11.3.1 Shanghai Institute Corporation Information
11.3.2 Shanghai Institute Description, Business Overview and Total Revenue
11.3.3 Shanghai Institute Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Shanghai Institute Varicella Vaccine Products Offered
11.3.5 Shanghai Institute Recent Development
11.4 BCHT
11.4.1 BCHT Corporation Information
11.4.2 BCHT Description, Business Overview and Total Revenue
11.4.3 BCHT Sales, Revenue and Gross Margin (2015-2020)
11.4.4 BCHT Varicella Vaccine Products Offered
11.4.5 BCHT Recent Development
11.5 Changsheng
11.5.1 Changsheng Corporation Information
11.5.2 Changsheng Description, Business Overview and Total Revenue
11.5.3 Changsheng Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Changsheng Varicella Vaccine Products Offered
11.5.5 Changsheng Recent Development
11.6 Keygen
11.6.1 Keygen Corporation Information
11.6.2 Keygen Description, Business Overview and Total Revenue
11.6.3 Keygen Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Keygen Varicella Vaccine Products Offered
11.6.5 Keygen Recent Development
11.7 Green Cross
11.7.1 Green Cross Corporation Information
11.7.2 Green Cross Description, Business Overview and Total Revenue
11.7.3 Green Cross Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Green Cross Varicella Vaccine Products Offered
11.7.5 Green Cross Recent Development
11.8 Biken
11.8.1 Biken Corporation Information
11.8.2 Biken Description, Business Overview and Total Revenue
11.8.3 Biken Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Biken Varicella Vaccine Products Offered
11.8.5 Biken Recent Development
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description, Business Overview and Total Revenue
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Varicella Vaccine Products Offered
11.1.5 Merck Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Varicella Vaccine Market Estimates and Projections by Region
12.1.1 Global Varicella Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Varicella Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Varicella Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Varicella Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Varicella Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Varicella Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Varicella Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Varicella Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Varicella Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Varicella Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Varicella Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Varicella Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Varicella Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Varicella Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Varicella Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Varicella Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Varicella Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Varicella Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Varicella Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Varicella Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Varicella Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Varicella Vaccine Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Varicella Vaccine Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Varicella Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Varicella Vaccine Product Introduction
1.2 Market Segments
1.3 Key Varicella Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Varicella Vaccine Market Size Growth Rate by Type
1.4.2 Injection
1.4.3 Freeze-dried powder
1.5 Market by Application
1.5.1 Global Varicella Vaccine Market Size Growth Rate by Application
1.5.2 Kids Injection
1.5.3 Adults Injection
1.6 Coronavirus Disease 2019 (Covid-19): Varicella Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the Varicella Vaccine Industry
1.6.1.1 Varicella Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Varicella Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Varicella Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Varicella Vaccine Market Size Estimates and Forecasts
2.1.1 Global Varicella Vaccine Revenue 2015-2026
2.1.2 Global Varicella Vaccine Sales 2015-2026
2.2 Varicella Vaccine Market Size by Region: 2020 Versus 2026
2.2.1 Global Varicella Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Varicella Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL VARICELLA VACCINE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Varicella Vaccine Sales by Manufacturers
3.1.1 Varicella Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Varicella Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Varicella Vaccine Revenue by Manufacturers
3.2.1 Varicella Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Varicella Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Varicella Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Varicella Vaccine Revenue in 2019
3.2.5 Global Varicella Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Varicella Vaccine Price by Manufacturers
3.4 Varicella Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Varicella Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Varicella Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Varicella Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Varicella Vaccine Market Size by Type (2015-2020)
4.1.1 Global Varicella Vaccine Sales by Type (2015-2020)
4.1.2 Global Varicella Vaccine Revenue by Type (2015-2020)
4.1.3 Varicella Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Varicella Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Varicella Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Varicella Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Varicella Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Varicella Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Varicella Vaccine Market Size by Application (2015-2020)
5.1.1 Global Varicella Vaccine Sales by Application (2015-2020)
5.1.2 Global Varicella Vaccine Revenue by Application (2015-2020)
5.1.3 Varicella Vaccine Price by Application (2015-2020)
5.2 Varicella Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Varicella Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Varicella Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Varicella Vaccine Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Varicella Vaccine by Country
6.1.1 North America Varicella Vaccine Sales by Country
6.1.2 North America Varicella Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Varicella Vaccine Market Facts & Figures by Type
6.3 North America Varicella Vaccine Market Facts & Figures by Application
7 EUROPE
7.1 Europe Varicella Vaccine by Country
7.1.1 Europe Varicella Vaccine Sales by Country
7.1.2 Europe Varicella Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Varicella Vaccine Market Facts & Figures by Type
7.3 Europe Varicella Vaccine Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Varicella Vaccine by Region
8.1.1 Asia Pacific Varicella Vaccine Sales by Region
8.1.2 Asia Pacific Varicella Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Varicella Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Varicella Vaccine Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Varicella Vaccine by Country
9.1.1 Latin America Varicella Vaccine Sales by Country
9.1.2 Latin America Varicella Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Varicella Vaccine Market Facts & Figures by Type
9.3 Central & South America Varicella Vaccine Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Varicella Vaccine by Country
10.1.1 Middle East and Africa Varicella Vaccine Sales by Country
10.1.2 Middle East and Africa Varicella Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Varicella Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Varicella Vaccine Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description, Business Overview and Total Revenue
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Varicella Vaccine Products Offered
11.1.5 Merck Recent Development
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Description, Business Overview and Total Revenue
11.2.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GSK Varicella Vaccine Products Offered
11.2.5 GSK Recent Development
11.3 Shanghai Institute
11.3.1 Shanghai Institute Corporation Information
11.3.2 Shanghai Institute Description, Business Overview and Total Revenue
11.3.3 Shanghai Institute Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Shanghai Institute Varicella Vaccine Products Offered
11.3.5 Shanghai Institute Recent Development
11.4 BCHT
11.4.1 BCHT Corporation Information
11.4.2 BCHT Description, Business Overview and Total Revenue
11.4.3 BCHT Sales, Revenue and Gross Margin (2015-2020)
11.4.4 BCHT Varicella Vaccine Products Offered
11.4.5 BCHT Recent Development
11.5 Changsheng
11.5.1 Changsheng Corporation Information
11.5.2 Changsheng Description, Business Overview and Total Revenue
11.5.3 Changsheng Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Changsheng Varicella Vaccine Products Offered
11.5.5 Changsheng Recent Development
11.6 Keygen
11.6.1 Keygen Corporation Information
11.6.2 Keygen Description, Business Overview and Total Revenue
11.6.3 Keygen Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Keygen Varicella Vaccine Products Offered
11.6.5 Keygen Recent Development
11.7 Green Cross
11.7.1 Green Cross Corporation Information
11.7.2 Green Cross Description, Business Overview and Total Revenue
11.7.3 Green Cross Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Green Cross Varicella Vaccine Products Offered
11.7.5 Green Cross Recent Development
11.8 Biken
11.8.1 Biken Corporation Information
11.8.2 Biken Description, Business Overview and Total Revenue
11.8.3 Biken Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Biken Varicella Vaccine Products Offered
11.8.5 Biken Recent Development
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description, Business Overview and Total Revenue
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Varicella Vaccine Products Offered
11.1.5 Merck Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Varicella Vaccine Market Estimates and Projections by Region
12.1.1 Global Varicella Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Varicella Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Varicella Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Varicella Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Varicella Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Varicella Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Varicella Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Varicella Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Varicella Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Varicella Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Varicella Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Varicella Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Varicella Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Varicella Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Varicella Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Varicella Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Varicella Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Varicella Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Varicella Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Varicella Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Varicella Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Varicella Vaccine Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Varicella Vaccine Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Varicella Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Varicella Vaccine Market Segments
Table 2. Ranking of Global Top Varicella Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Varicella Vaccine Market Size Growth Rate by Type 2020-2026 (M Doses) & (US$ Million)
Table 4. Major Manufacturers of Injection
Table 5. Major Manufacturers of Freeze-dried powder
Table 6. COVID-19 Impact Global Market: (Four Varicella Vaccine Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Varicella Vaccine Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Varicella Vaccine Players to Combat Covid-19 Impact
Table 11. Global Varicella Vaccine Market Size Growth Rate by Application 2020-2026 (M Doses)
Table 12. Global Varicella Vaccine Market Size by Region (M Doses) & (US$ Million): 2020 VS 2026
Table 13. Global Varicella Vaccine Sales by Regions 2015-2020 (M Doses)
Table 14. Global Varicella Vaccine Sales Market Share by Regions (2015-2020)
Table 15. Global Varicella Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Varicella Vaccine Sales by Manufacturers (2015-2020) (M Doses)
Table 17. Global Varicella Vaccine Sales Share by Manufacturers (2015-2020)
Table 18. Global Varicella Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Varicella Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Varicella Vaccine as of 2019)
Table 20. Varicella Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Varicella Vaccine Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Varicella Vaccine Price (2015-2020) (USD/Dose)
Table 23. Varicella Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Varicella Vaccine Product Type
Table 25. Date of International Manufacturers Enter into Varicella Vaccine Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Varicella Vaccine Sales by Type (2015-2020) (M Doses)
Table 28. Global Varicella Vaccine Sales Share by Type (2015-2020)
Table 29. Global Varicella Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Varicella Vaccine Revenue Share by Type (2015-2020)
Table 31. Varicella Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 32. Global Varicella Vaccine Sales by Application (2015-2020) (M Doses)
Table 33. Global Varicella Vaccine Sales Share by Application (2015-2020)
Table 34. North America Varicella Vaccine Sales by Country (2015-2020) (M Doses)
Table 35. North America Varicella Vaccine Sales Market Share by Country (2015-2020)
Table 36. North America Varicella Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Varicella Vaccine Revenue Market Share by Country (2015-2020)
Table 38. North America Varicella Vaccine Sales by Type (2015-2020) (M Doses)
Table 39. North America Varicella Vaccine Sales Market Share by Type (2015-2020)
Table 40. North America Varicella Vaccine Sales by Application (2015-2020) (M Doses)
Table 41. North America Varicella Vaccine Sales Market Share by Application (2015-2020)
Table 42. Europe Varicella Vaccine Sales by Country (2015-2020) (M Doses)
Table 43. Europe Varicella Vaccine Sales Market Share by Country (2015-2020)
Table 44. Europe Varicella Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Varicella Vaccine Revenue Market Share by Country (2015-2020)
Table 46. Europe Varicella Vaccine Sales by Type (2015-2020) (M Doses)
Table 47. Europe Varicella Vaccine Sales Market Share by Type (2015-2020)
Table 48. Europe Varicella Vaccine Sales by Application (2015-2020) (M Doses)
Table 49. Europe Varicella Vaccine Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Varicella Vaccine Sales by Region (2015-2020) (M Doses)
Table 51. Asia Pacific Varicella Vaccine Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Varicella Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Varicella Vaccine Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Varicella Vaccine Sales by Type (2015-2020) (M Doses)
Table 55. Asia Pacific Varicella Vaccine Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Varicella Vaccine Sales by Application (2015-2020) (M Doses)
Table 57. Asia Pacific Varicella Vaccine Sales Market Share by Application (2015-2020)
Table 58. Latin America Varicella Vaccine Sales by Country (2015-2020) (M Doses)
Table 59. Latin America Varicella Vaccine Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Varicella Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Varicella Vaccine Revenue Market Share by Country (2015-2020)
Table 62. Latin America Varicella Vaccine Sales by Type (2015-2020) (M Doses)
Table 63. Latin America Varicella Vaccine Sales Market Share by Type (2015-2020)
Table 64. Latin America Varicella Vaccine Sales by Application (2015-2020) (M Doses)
Table 65. Latin America Varicella Vaccine Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Varicella Vaccine Sales by Country (2015-2020) (M Doses)
Table 67. Middle East and Africa Varicella Vaccine Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Varicella Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Varicella Vaccine Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Varicella Vaccine Sales by Type (2015-2020) (M Doses)
Table 71. Middle East and Africa Varicella Vaccine Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Varicella Vaccine Sales by Application (2015-2020) (M Doses)
Table 73. Middle East and Africa Varicella Vaccine Sales Market Share by Application (2015-2020)
Table 74. Merck Corporation Information
Table 75. Merck Description and Major Businesses
Table 76. Merck Varicella Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 77. Merck Product
Table 78. Merck Recent Development
Table 79. GSK Corporation Information
Table 80. GSK Description and Major Businesses
Table 81. GSK Varicella Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 82. GSK Product
Table 83. GSK Recent Development
Table 84. Shanghai Institute Corporation Information
Table 85. Shanghai Institute Description and Major Businesses
Table 86. Shanghai Institute Varicella Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 87. Shanghai Institute Product
Table 88. Shanghai Institute Recent Development
Table 89. BCHT Corporation Information
Table 90. BCHT Description and Major Businesses
Table 91. BCHT Varicella Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 92. BCHT Product
Table 93. BCHT Recent Development
Table 94. Changsheng Corporation Information
Table 95. Changsheng Description and Major Businesses
Table 96. Changsheng Varicella Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 97. Changsheng Product
Table 98. Changsheng Recent Development
Table 99. Keygen Corporation Information
Table 100. Keygen Description and Major Businesses
Table 101. Keygen Varicella Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 102. Keygen Product
Table 103. Keygen Recent Development
Table 104. Green Cross Corporation Information
Table 105. Green Cross Description and Major Businesses
Table 106. Green Cross Varicella Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 107. Green Cross Product
Table 108. Green Cross Recent Development
Table 109. Biken Corporation Information
Table 110. Biken Description and Major Businesses
Table 111. Biken Varicella Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 112. Biken Product
Table 113. Biken Recent Development
Table 114. Global Varicella Vaccine Sales Forecast by Regions (2021-2026) (M Doses)
Table 115. Global Varicella Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 116. Global Varicella Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 117. Global Varicella Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 118. North America: Varicella Vaccine Sales Forecast by Country (2021-2026) (M Doses)
Table 119. North America: Varicella Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Europe: Varicella Vaccine Sales Forecast by Country (2021-2026) (M Doses)
Table 121. Europe: Varicella Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Asia Pacific: Varicella Vaccine Sales Forecast by Region (2021-2026) (M Doses)
Table 123. Asia Pacific: Varicella Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Latin America: Varicella Vaccine Sales Forecast by Country (2021-2026) (M Doses)
Table 125. Latin America: Varicella Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Middle East and Africa: Varicella Vaccine Sales Forecast by Country (2021-2026) (M Doses)
Table 127. Middle East and Africa: Varicella Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 129. Key Challenges
Table 130. Market Risks
Table 131. Main Points Interviewed from Key Varicella Vaccine Players
Table 132. Varicella Vaccine Customers List
Table 133. Varicella Vaccine Distributors List
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
Table 1. Varicella Vaccine Market Segments
Table 2. Ranking of Global Top Varicella Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Varicella Vaccine Market Size Growth Rate by Type 2020-2026 (M Doses) & (US$ Million)
Table 4. Major Manufacturers of Injection
Table 5. Major Manufacturers of Freeze-dried powder
Table 6. COVID-19 Impact Global Market: (Four Varicella Vaccine Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Varicella Vaccine Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Varicella Vaccine Players to Combat Covid-19 Impact
Table 11. Global Varicella Vaccine Market Size Growth Rate by Application 2020-2026 (M Doses)
Table 12. Global Varicella Vaccine Market Size by Region (M Doses) & (US$ Million): 2020 VS 2026
Table 13. Global Varicella Vaccine Sales by Regions 2015-2020 (M Doses)
Table 14. Global Varicella Vaccine Sales Market Share by Regions (2015-2020)
Table 15. Global Varicella Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Varicella Vaccine Sales by Manufacturers (2015-2020) (M Doses)
Table 17. Global Varicella Vaccine Sales Share by Manufacturers (2015-2020)
Table 18. Global Varicella Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Varicella Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Varicella Vaccine as of 2019)
Table 20. Varicella Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Varicella Vaccine Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Varicella Vaccine Price (2015-2020) (USD/Dose)
Table 23. Varicella Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Varicella Vaccine Product Type
Table 25. Date of International Manufacturers Enter into Varicella Vaccine Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Varicella Vaccine Sales by Type (2015-2020) (M Doses)
Table 28. Global Varicella Vaccine Sales Share by Type (2015-2020)
Table 29. Global Varicella Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Varicella Vaccine Revenue Share by Type (2015-2020)
Table 31. Varicella Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 32. Global Varicella Vaccine Sales by Application (2015-2020) (M Doses)
Table 33. Global Varicella Vaccine Sales Share by Application (2015-2020)
Table 34. North America Varicella Vaccine Sales by Country (2015-2020) (M Doses)
Table 35. North America Varicella Vaccine Sales Market Share by Country (2015-2020)
Table 36. North America Varicella Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Varicella Vaccine Revenue Market Share by Country (2015-2020)
Table 38. North America Varicella Vaccine Sales by Type (2015-2020) (M Doses)
Table 39. North America Varicella Vaccine Sales Market Share by Type (2015-2020)
Table 40. North America Varicella Vaccine Sales by Application (2015-2020) (M Doses)
Table 41. North America Varicella Vaccine Sales Market Share by Application (2015-2020)
Table 42. Europe Varicella Vaccine Sales by Country (2015-2020) (M Doses)
Table 43. Europe Varicella Vaccine Sales Market Share by Country (2015-2020)
Table 44. Europe Varicella Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Varicella Vaccine Revenue Market Share by Country (2015-2020)
Table 46. Europe Varicella Vaccine Sales by Type (2015-2020) (M Doses)
Table 47. Europe Varicella Vaccine Sales Market Share by Type (2015-2020)
Table 48. Europe Varicella Vaccine Sales by Application (2015-2020) (M Doses)
Table 49. Europe Varicella Vaccine Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Varicella Vaccine Sales by Region (2015-2020) (M Doses)
Table 51. Asia Pacific Varicella Vaccine Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Varicella Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Varicella Vaccine Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Varicella Vaccine Sales by Type (2015-2020) (M Doses)
Table 55. Asia Pacific Varicella Vaccine Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Varicella Vaccine Sales by Application (2015-2020) (M Doses)
Table 57. Asia Pacific Varicella Vaccine Sales Market Share by Application (2015-2020)
Table 58. Latin America Varicella Vaccine Sales by Country (2015-2020) (M Doses)
Table 59. Latin America Varicella Vaccine Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Varicella Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Varicella Vaccine Revenue Market Share by Country (2015-2020)
Table 62. Latin America Varicella Vaccine Sales by Type (2015-2020) (M Doses)
Table 63. Latin America Varicella Vaccine Sales Market Share by Type (2015-2020)
Table 64. Latin America Varicella Vaccine Sales by Application (2015-2020) (M Doses)
Table 65. Latin America Varicella Vaccine Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Varicella Vaccine Sales by Country (2015-2020) (M Doses)
Table 67. Middle East and Africa Varicella Vaccine Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Varicella Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Varicella Vaccine Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Varicella Vaccine Sales by Type (2015-2020) (M Doses)
Table 71. Middle East and Africa Varicella Vaccine Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Varicella Vaccine Sales by Application (2015-2020) (M Doses)
Table 73. Middle East and Africa Varicella Vaccine Sales Market Share by Application (2015-2020)
Table 74. Merck Corporation Information
Table 75. Merck Description and Major Businesses
Table 76. Merck Varicella Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 77. Merck Product
Table 78. Merck Recent Development
Table 79. GSK Corporation Information
Table 80. GSK Description and Major Businesses
Table 81. GSK Varicella Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 82. GSK Product
Table 83. GSK Recent Development
Table 84. Shanghai Institute Corporation Information
Table 85. Shanghai Institute Description and Major Businesses
Table 86. Shanghai Institute Varicella Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 87. Shanghai Institute Product
Table 88. Shanghai Institute Recent Development
Table 89. BCHT Corporation Information
Table 90. BCHT Description and Major Businesses
Table 91. BCHT Varicella Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 92. BCHT Product
Table 93. BCHT Recent Development
Table 94. Changsheng Corporation Information
Table 95. Changsheng Description and Major Businesses
Table 96. Changsheng Varicella Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 97. Changsheng Product
Table 98. Changsheng Recent Development
Table 99. Keygen Corporation Information
Table 100. Keygen Description and Major Businesses
Table 101. Keygen Varicella Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 102. Keygen Product
Table 103. Keygen Recent Development
Table 104. Green Cross Corporation Information
Table 105. Green Cross Description and Major Businesses
Table 106. Green Cross Varicella Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 107. Green Cross Product
Table 108. Green Cross Recent Development
Table 109. Biken Corporation Information
Table 110. Biken Description and Major Businesses
Table 111. Biken Varicella Vaccine Production (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 112. Biken Product
Table 113. Biken Recent Development
Table 114. Global Varicella Vaccine Sales Forecast by Regions (2021-2026) (M Doses)
Table 115. Global Varicella Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 116. Global Varicella Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 117. Global Varicella Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 118. North America: Varicella Vaccine Sales Forecast by Country (2021-2026) (M Doses)
Table 119. North America: Varicella Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Europe: Varicella Vaccine Sales Forecast by Country (2021-2026) (M Doses)
Table 121. Europe: Varicella Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Asia Pacific: Varicella Vaccine Sales Forecast by Region (2021-2026) (M Doses)
Table 123. Asia Pacific: Varicella Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Latin America: Varicella Vaccine Sales Forecast by Country (2021-2026) (M Doses)
Table 125. Latin America: Varicella Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Middle East and Africa: Varicella Vaccine Sales Forecast by Country (2021-2026) (M Doses)
Table 127. Middle East and Africa: Varicella Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 129. Key Challenges
Table 130. Market Risks
Table 131. Main Points Interviewed from Key Varicella Vaccine Players
Table 132. Varicella Vaccine Customers List
Table 133. Varicella Vaccine Distributors List
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Varicella Vaccine Product Picture
Figure 2. Global Varicella Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Injection Product Picture
Figure 4. Freeze-dried powder Product Picture
Figure 5. Global Varicella Vaccine Sales Market Share by Application in 2020 & 2026
Figure 6. Kids Injection
Figure 7. Adults Injection
Figure 8. Varicella Vaccine Report Years Considered
Figure 9. Global Varicella Vaccine Market Size 2015-2026 (US$ Million)
Figure 10. Global Varicella Vaccine Sales 2015-2026 (M Doses)
Figure 11. Global Varicella Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Varicella Vaccine Sales Market Share by Region (2015-2020)
Figure 13. Global Varicella Vaccine Sales Market Share by Region in 2019
Figure 14. Global Varicella Vaccine Revenue Market Share by Region (2015-2020)
Figure 15. Global Varicella Vaccine Revenue Market Share by Region in 2019
Figure 16. Global Varicella Vaccine Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Varicella Vaccine Revenue in 2019
Figure 18. Varicella Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Varicella Vaccine Sales Market Share by Type (2015-2020)
Figure 20. Global Varicella Vaccine Sales Market Share by Type in 2019
Figure 21. Global Varicella Vaccine Revenue Market Share by Type (2015-2020)
Figure 22. Global Varicella Vaccine Revenue Market Share by Type in 2019
Figure 23. Global Varicella Vaccine Market Share by Price Range (2015-2020)
Figure 24. Global Varicella Vaccine Sales Market Share by Application (2015-2020)
Figure 25. Global Varicella Vaccine Sales Market Share by Application in 2019
Figure 26. Global Varicella Vaccine Revenue Market Share by Application (2015-2020)
Figure 27. Global Varicella Vaccine Revenue Market Share by Application in 2019
Figure 28. North America Varicella Vaccine Sales Growth Rate 2015-2020 (M Doses)
Figure 29. North America Varicella Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Varicella Vaccine Sales Market Share by Country in 2019
Figure 31. North America Varicella Vaccine Revenue Market Share by Country in 2019
Figure 32. U.S. Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 33. U.S. Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 35. Canada Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Varicella Vaccine Market Share by Type in 2019
Figure 37. North America Varicella Vaccine Market Share by Application in 2019
Figure 38. Europe Varicella Vaccine Sales Growth Rate 2015-2020 (M Doses)
Figure 39. Europe Varicella Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Varicella Vaccine Sales Market Share by Country in 2019
Figure 41. Europe Varicella Vaccine Revenue Market Share by Country in 2019
Figure 42. Germany Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 43. Germany Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 45. France Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 47. U.K. Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 49. Italy Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 51. Russia Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Varicella Vaccine Market Share by Type in 2019
Figure 53. Europe Varicella Vaccine Market Share by Application in 2019
Figure 54. Asia Pacific Varicella Vaccine Sales Growth Rate 2015-2020 (M Doses)
Figure 55. Asia Pacific Varicella Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Varicella Vaccine Sales Market Share by Region in 2019
Figure 57. Asia Pacific Varicella Vaccine Revenue Market Share by Region in 2019
Figure 58. China Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 59. China Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 61. Japan Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 63. South Korea Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 65. India Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 67. Australia Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 69. Taiwan Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 71. Indonesia Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 73. Thailand Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 75. Malaysia Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 77. Philippines Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 79. Vietnam Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Varicella Vaccine Market Share by Type in 2019
Figure 81. Asia Pacific Varicella Vaccine Market Share by Application in 2019
Figure 82. Latin America Varicella Vaccine Sales Growth Rate 2015-2020 (M Doses)
Figure 83. Latin America Varicella Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Varicella Vaccine Sales Market Share by Country in 2019
Figure 85. Latin America Varicella Vaccine Revenue Market Share by Country in 2019
Figure 86. Mexico Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 87. Mexico Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 89. Brazil Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 91. Argentina Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Varicella Vaccine Market Share by Type in 2019
Figure 93. Latin America Varicella Vaccine Market Share by Application in 2019
Figure 94. Middle East and Africa Varicella Vaccine Sales Growth Rate 2015-2020 (M Doses)
Figure 95. Middle East and Africa Varicella Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Varicella Vaccine Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Varicella Vaccine Revenue Market Share by Country in 2019
Figure 98. Turkey Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 99. Turkey Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 101. Saudi Arabia Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. UAE Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 103. UAE Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Varicella Vaccine Market Share by Type in 2019
Figure 105. Middle East and Africa Varicella Vaccine Market Share by Application in 2019
Figure 106. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Shanghai Institute Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. BCHT Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Changsheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Keygen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Green Cross Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Biken Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. North America Varicella Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 115. North America Varicella Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Varicella Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 117. Europe Varicella Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Varicella Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 119. Asia Pacific Varicella Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Varicella Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 121. Latin America Varicella Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Varicella Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 123. Middle East and Africa Varicella Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
Figure 1. Varicella Vaccine Product Picture
Figure 2. Global Varicella Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Injection Product Picture
Figure 4. Freeze-dried powder Product Picture
Figure 5. Global Varicella Vaccine Sales Market Share by Application in 2020 & 2026
Figure 6. Kids Injection
Figure 7. Adults Injection
Figure 8. Varicella Vaccine Report Years Considered
Figure 9. Global Varicella Vaccine Market Size 2015-2026 (US$ Million)
Figure 10. Global Varicella Vaccine Sales 2015-2026 (M Doses)
Figure 11. Global Varicella Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Varicella Vaccine Sales Market Share by Region (2015-2020)
Figure 13. Global Varicella Vaccine Sales Market Share by Region in 2019
Figure 14. Global Varicella Vaccine Revenue Market Share by Region (2015-2020)
Figure 15. Global Varicella Vaccine Revenue Market Share by Region in 2019
Figure 16. Global Varicella Vaccine Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Varicella Vaccine Revenue in 2019
Figure 18. Varicella Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Varicella Vaccine Sales Market Share by Type (2015-2020)
Figure 20. Global Varicella Vaccine Sales Market Share by Type in 2019
Figure 21. Global Varicella Vaccine Revenue Market Share by Type (2015-2020)
Figure 22. Global Varicella Vaccine Revenue Market Share by Type in 2019
Figure 23. Global Varicella Vaccine Market Share by Price Range (2015-2020)
Figure 24. Global Varicella Vaccine Sales Market Share by Application (2015-2020)
Figure 25. Global Varicella Vaccine Sales Market Share by Application in 2019
Figure 26. Global Varicella Vaccine Revenue Market Share by Application (2015-2020)
Figure 27. Global Varicella Vaccine Revenue Market Share by Application in 2019
Figure 28. North America Varicella Vaccine Sales Growth Rate 2015-2020 (M Doses)
Figure 29. North America Varicella Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Varicella Vaccine Sales Market Share by Country in 2019
Figure 31. North America Varicella Vaccine Revenue Market Share by Country in 2019
Figure 32. U.S. Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 33. U.S. Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 35. Canada Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Varicella Vaccine Market Share by Type in 2019
Figure 37. North America Varicella Vaccine Market Share by Application in 2019
Figure 38. Europe Varicella Vaccine Sales Growth Rate 2015-2020 (M Doses)
Figure 39. Europe Varicella Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Varicella Vaccine Sales Market Share by Country in 2019
Figure 41. Europe Varicella Vaccine Revenue Market Share by Country in 2019
Figure 42. Germany Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 43. Germany Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 45. France Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 47. U.K. Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 49. Italy Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 51. Russia Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Varicella Vaccine Market Share by Type in 2019
Figure 53. Europe Varicella Vaccine Market Share by Application in 2019
Figure 54. Asia Pacific Varicella Vaccine Sales Growth Rate 2015-2020 (M Doses)
Figure 55. Asia Pacific Varicella Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Varicella Vaccine Sales Market Share by Region in 2019
Figure 57. Asia Pacific Varicella Vaccine Revenue Market Share by Region in 2019
Figure 58. China Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 59. China Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 61. Japan Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 63. South Korea Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 65. India Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 67. Australia Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 69. Taiwan Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 71. Indonesia Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 73. Thailand Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 75. Malaysia Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 77. Philippines Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 79. Vietnam Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Varicella Vaccine Market Share by Type in 2019
Figure 81. Asia Pacific Varicella Vaccine Market Share by Application in 2019
Figure 82. Latin America Varicella Vaccine Sales Growth Rate 2015-2020 (M Doses)
Figure 83. Latin America Varicella Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Varicella Vaccine Sales Market Share by Country in 2019
Figure 85. Latin America Varicella Vaccine Revenue Market Share by Country in 2019
Figure 86. Mexico Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 87. Mexico Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 89. Brazil Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 91. Argentina Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Varicella Vaccine Market Share by Type in 2019
Figure 93. Latin America Varicella Vaccine Market Share by Application in 2019
Figure 94. Middle East and Africa Varicella Vaccine Sales Growth Rate 2015-2020 (M Doses)
Figure 95. Middle East and Africa Varicella Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Varicella Vaccine Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Varicella Vaccine Revenue Market Share by Country in 2019
Figure 98. Turkey Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 99. Turkey Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 101. Saudi Arabia Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. UAE Varicella Vaccine Sales Growth Rate (2015-2020) (M Doses)
Figure 103. UAE Varicella Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Varicella Vaccine Market Share by Type in 2019
Figure 105. Middle East and Africa Varicella Vaccine Market Share by Application in 2019
Figure 106. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Shanghai Institute Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. BCHT Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Changsheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Keygen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Green Cross Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Biken Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. North America Varicella Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 115. North America Varicella Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Varicella Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 117. Europe Varicella Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Varicella Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 119. Asia Pacific Varicella Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Varicella Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 121. Latin America Varicella Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Varicella Vaccine Sales Growth Rate Forecast (2021-2026) (M Doses)
Figure 123. Middle East and Africa Varicella Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
